- Home
- ISTR vs PRLD Comparison
ISTR vs PRLD Comparison
Compare ISTR & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISTR | PRLD |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | 79 |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.5M | 391.1M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ISTR | PRLD |
|---|---|---|
| Price | $29.46 | $4.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $31.50 | $5.67 |
| AVG Volume (30 Days) | 226.7K | ★ 523.6K |
| Earning Date | 04-20-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | 4.41 | ★ 23.21 |
| EPS | ★ 0.77 | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | $66.56 | $320.10 |
| Revenue Next Year | $5.18 | $100.00 |
| P/E Ratio | $38.30 | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $21.00 | $0.75 |
| 52 Week High | $30.68 | $5.69 |
Technical Indicators
Market Signals| Indicator | ISTR | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 59.52 |
| Support Level | $28.90 | $3.92 |
| Resistance Level | $30.53 | $5.43 |
| Average True Range (ATR) | 0.77 | 0.44 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 28.74 | 54.65 |
Price Performance
Historical ComparisonAbout ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.